| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
475,140,000 |
| Market
Cap: |
75.31(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$145.54 - $200.09 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drugs - Generic |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Zoetis is a holding company. Through its subsidiaries, Co. is engaged in the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. Co.'s segments are: the U.S. and International. Co.'s main product categories are: vaccines, anti-infectives, parasiticides, dermatology products, other pharmaceutical products, medicated feed additives, and animal health diagnostics. Co.'s other non-pharmaceutical product categories include nutritionals and agribusiness, as well as products and services in biodevices, genetic tests and precision livestock farming.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
20,350 |
38,619 |
78,472 |
115,296 |
| Total Sell Value |
$3,760,250 |
$7,082,475 |
$14,229,167 |
$20,711,686 |
| Total People Sold |
3 |
3 |
5 |
5 |
| Total Sell Transactions |
7 |
12 |
19 |
27 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lagano Roxanne |
Executive Vice President |
• – – |
2021-02-19 |
4 |
OE |
$41.83 |
$250,980 |
D/D |
6,000 |
48,083 |
|
- |
|
| Chen Heidi C. |
Executive Vice President |
• – – |
2021-02-18 |
4 |
AS |
$170.04 |
$102,024 |
D/D |
(600) |
24,645 |
|
12% |
|
| Chen Heidi C. |
Executive Vice President |
• – – |
2021-02-18 |
4 |
OE |
$55.02 |
$33,012 |
D/D |
600 |
25,245 |
|
- |
|
| Trawicki Roman |
Executive Vice President |
• – – |
2021-02-17 |
4 |
AS |
$165.82 |
$744,698 |
D/D |
(4,491) |
3,623 |
|
11% |
|
| Trawicki Roman |
Executive Vice President |
• – – |
2021-02-17 |
4 |
OE |
$73.24 |
$240,593 |
D/D |
3,285 |
8,114 |
|
- |
|
| David Glenn |
Chief Financial Officer |
• – – |
2021-02-16 |
4 |
AS |
$168.21 |
$4,439,965 |
D/D |
(26,285) |
32,901 |
|
13% |
|
| David Glenn |
Chief Financial Officer |
• – – |
2021-02-16 |
4 |
OE |
$73.24 |
$1,925,113 |
D/D |
26,285 |
59,186 |
|
- |
|
| Steere William C Jr |
Director |
– • – |
2021-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,779 |
18,904 |
|
- |
|
| Chen Heidi C. |
Executive Vice President |
• – – |
2021-02-13 |
4 |
D |
$166.71 |
$799,208 |
D/D |
(4,794) |
24,645 |
|
- |
|
| Chen Heidi C. |
Executive Vice President |
• – – |
2021-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,104 |
27,595 |
|
- |
|
| Scully Robert W |
Director |
– • – |
2021-02-13 |
4 |
D |
$166.71 |
$166,210 |
D/D |
(997) |
10,589 |
|
- |
|
| Scully Robert W |
Director |
– • – |
2021-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,779 |
11,586 |
|
- |
|
| David Glenn |
Chief Financial Officer |
• – – |
2021-02-13 |
4 |
D |
$166.71 |
$1,201,812 |
D/D |
(7,209) |
32,901 |
|
- |
|
| David Glenn |
Chief Financial Officer |
• – – |
2021-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,233 |
37,345 |
|
- |
|
| Knupp Catherine A. |
Executive Vice President |
• – – |
2021-02-13 |
4 |
D |
$166.71 |
$922,907 |
D/D |
(5,536) |
61,925 |
|
- |
|
| Knupp Catherine A. |
Executive Vice President |
• – – |
2021-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
17,093 |
65,462 |
|
- |
|
| Norden Gregory |
Director |
– • – |
2021-02-13 |
4 |
D |
$166.71 |
$116,197 |
D/D |
(697) |
8,389 |
|
- |
|
| Norden Gregory |
Director |
– • – |
2021-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,779 |
9,086 |
|
- |
|
| Kelly Robert Edward |
Executive Vice President |
• – – |
2021-02-13 |
4 |
D |
$166.71 |
$194,384 |
D/D |
(1,166) |
9,815 |
|
- |
|
| Kelly Robert Edward |
Executive Vice President |
• – – |
2021-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,277 |
10,507 |
|
- |
|
| Lagano Roxanne |
Executive Vice President |
• – – |
2021-02-13 |
4 |
D |
$166.71 |
$546,976 |
D/D |
(3,281) |
42,083 |
|
- |
|
| Lagano Roxanne |
Executive Vice President |
• – – |
2021-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,684 |
44,073 |
|
- |
|
| Rhodes Linda |
Director |
– • – |
2021-02-13 |
4 |
D |
$166.71 |
$102,027 |
D/D |
(612) |
3,635 |
|
- |
|
| Rhodes Linda |
Director |
– • – |
2021-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,779 |
4,247 |
|
- |
|
| Damelio Frank A |
Director |
– • – |
2021-02-13 |
4 |
D |
$166.71 |
$147,872 |
D/D |
(887) |
14,808 |
|
- |
|
737 Records found
|
|
Page 10 of 30 |
|
|
0.74 (0.46%) 
